GlobalData on MSN
Takeda’s oral TYK2 blocker outperforms Sotyktu in PsA trial
Based on this data and data from two other Phase III trials, Takeda will file for the approval of zasocitinib in PsA.
Tulsa Mayor Monroe Nichols and residents are pushing back against a proposed $25 monthly rate increase from PSO.
Public Service Company of Oklahoma filed a rate increase last year that would hike average customer bills by 15%.
The Oklahoma Corporation Commission approves PSO’s request to purchase a power plant in Jenks. PSO first asked OCC to buy the Green Country Power Plant from Tokyo-based J-Power back in September. The ...
Bristol-Myers (BMY) stock is in focus as a psoriasis therapy from Takeda (TAK) outperforms the company's FDA approved therapy ...
POPCORN (PopcornStudio.ai), a Dubai-based emerging advertising technology company, has announced the launch of its new ...
Police acknowledge the findings by the Independent Police Conduct Authority (IPCA) regarding a Police Safety Order (PSO) ...
Takeda Pharmaceutical Company Limited TAK on Thursday shared topline results for the Phase 3 comparing zasocitinib (TAK-279) ...
The Independent Police Conduct Authority has found that Police in Central District were unjustified and acted unlawfully in ...
Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly ...
A volatile trading was observed at the Pakistan Stock Exchange (PSX), with the benchmark KSE-100 Index shedding over 450 ...
SEGA held a new NGS Headline livestream this past week for Phantasy Star Online 2 New Genesis, as we got a taste of what's coming throughout February 2026. The shorthand is that players will see the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results